Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Allergan Announces R&D Technology Review.


IRVINE, Calif. -- Allergan, Inc. (NYSE NYSE

See: New York Stock Exchange
:AGN AGN Again (Amateur Radio)
AGN Active Galactic Nucleus
AGN Acute Glomerulonephritis
AGN Accountants Global Network
AGN Air Gabon (ICAO code) 
) will host a R&D Technology Review on Monday, February 6, 2006 at 1 p.m. Eastern Time, 10 a.m. Pacific Time. The live Web cast can be accessed through the Allergan Web site, www.allergan.com, beginning at 1 p.m. Eastern Time, 10 a.m. Pacific Time. A replay of the discussion will be available soon after the call and can be accessed through www.allergan.com. The replay will be available for one week following the live call.

It is Allergan's policy to comply fully with Regulation FD. Therefore, Allergan intends to utilize this Web-casted event to discuss financially oriented o·ri·ent  
n.
1. Orient The countries of Asia, especially of eastern Asia.

2.
a. The luster characteristic of a pearl of high quality.

b. A pearl having exceptional luster.

3.
 goals and objectives and to disclose material company and industry-based topics in an open manner. Allergan does not plan to report or comment on its progress during the current fiscal quarter. Any statement made by others with respect to progress mid-quarter cannot be attributed to Allergan. During a quarter, Allergan's commentary is limited to discussions of public information, such as historic financial performance, and matters that are deemed to be immaterial Not essential or necessary; not important or pertinent; not decisive; of no substantial consequence; without weight; of no material significance.


immaterial adj.
. Allergan will make no comments with respect to market rumors For other uses, see Rumor (disambiguation).

Rumors is a farcical play by Neil Simon.

At its start, several affluent couples gather in the posh suburban residence of a couple for a dinner party celebrating their tenth anniversary.
 or speculation.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 6, 2006
Words:193
Previous Article:Avista Corp. Fourth Quarter 2005 Earnings Conference Call and Webcast Announced.
Next Article:TSR, Inc. Reports Financial Results for the Quarter Ended November 30, 2005 and Declares Quarterly Dividend of $0.08 Per Share.
Topics:



Related Articles
INAMED Corporation Receives an Unsolicited Preliminary Proposal from Allergan, Inc.
Allergan Extends Expiration Date of Exchange Offer for Inamed Corporation.
Allergan Receives Final Regulatory Approvals from Germany and Spain.
Allergan Extends Expiration Date of Exchange Offer for Inamed Corporation.
Allergan Announces Promotion of F. Michael Ball to President and Raymond Diradoorian to Executive Vice President, Global Technical Operations.
Allergan Extends Expiration Date of Inamed Exchange Offer.
Allergan Extends Expiration Date of Inamed Exchange Offer.
Allergan Announces Signing of FTC Consent Order; Anticipates Closing Exchange Offer Friday, March 10, 2006.
Allergan Announces FDA Approval of INAMED(R) Silicone-Filled Breast Implants for Breast Augmentation, Reconstruction and Revision Surgery.
Research and Markets: Allergan the Global Specialty Pharmaceutical Company Invests Approximately US$390 Million Per Year in Research & Development.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles